This brief analyzes how Bangladesh can strengthen its regulatory ecosystem to bolster vaccine and pharmaceutical manufacturing, improve public health outcomes, and better prepare for future health emergencies.
Explaining the challenges Bangladesh faces, the brief shows how aligning with global best practices would support its regulatory system, increase access to international markets, and encourage manufacturers to invest. It assesses how introducing policies to harmonize regulatory guidelines and prioritize infrastructure investment would make Bangladesh’s pharmaceutical sector more efficient and guarantee access to safe medicines.